To study possible age-related differences in the role of neuronal histaminergic pathways in the control of GH secretion, the effects of \g=a\-fluoromethylhistidine(\g=a\-FMH), an irreversible inhibitor of histamine (HA) synthesis, were examined on basal and opioid-induced GH 
Introduction
It has been reported that growth hormone (GH) concen¬ trations in blood of neonatal rats are high and relatively constant (Cocchi et al. 1976 ) whereas in adult rats GH secretion is pulsatile (Tannenbaum & Martin 1976) . These age-related differences in GH secretory pattern have been ascribed to ontogenic changes in the hypothalamic control of GH secretion. A tonic hypothalamic stimulation pre¬ sumably mediated by GH-releasing hormone (GHRH) prevails in the perinatal period (Khorram et al. 1983) while later in life a complex interaction between GHRH and somatostatin (SRIF) gives rise to the rhythmic GH se¬ cretion (Tannenbaum & Ling 1984 , Plotsky & Vale 1985 .
Characterization of the central neurotransmitter and peptidergic pathways involved in the regulation of GH secretion throughout life is still a matter of interest. Among the various neurotransmitters participating in the control of GH, the central histaminergic system has been previously reported to exert an inhibitory action on the physiological and pharmacologically induced GH secretion in adult rats (Netti et al. 1981 (Netti et al. , 1982 . However, the mechanisms underlying the GH inhibitory effects of histamine (HA) and the possible significance of neuronal histaminergic pathways in GH control during the immediate postnatal period have yet to be established. The developmental profile of HA associated with nerve terminal function resembles that of other monaminergic transmitters, starting from low level at birth and increasing progressively to adult values within the first 2-3 weeks of postnatal life (Subramanian et al. 1981 ). An effective depletion of the neurotransmitter pool of HA in the immature nervous system can be obtained by daily administration of the specific irreversible inhibitor of the HA-synthesizing enzyme, -fluoromethylhistidine (a-FMH), which has been reported to significantly decrease hypothalamic HA by postnatal day 9 (Slotkin et al. 1983 (Netti et al. 1982) .
In a first series of experiments, the effects of a single administration of a-FMH (100 mg/kg, i.p.) on basal and FK 33-824-induced GH release were studied. This dose of a-FMH was previously shown to be effective in altering GH secretion (Sibilla et al. 1993 respectively, P<0-05) (Fig. 4, inset) . In contrast, a 3-day i.e.v. treatment with a-FMH did not modify either basal plasma GH levels or the effect of the FK 33-824 challenge (Fig. 5 ).
No differences in GH and SRIF mRNA levels were observed in adult rats treated i.e.v. with a-FMH or vehicle, whereas a significant reduction (P<0'05) in GHRH mRNA levels was present in a-FMH-treated rats (26-7 ± 5-3% decrease vs control; P<0-05) ( increase in basal and opioid-induced GH secretion. Probably, the increase in plasma GH levels in HAdepleted neonatal rats was the result of enhanced GH synthesis since GH mRNA levels in the pituitary of a-FMH-treated rats were significantly higher than in controls.
The mechanism underlying the above results is presum¬ ably unrelated to a direct action of the histaminergic system on somatotrophs, since HA is unable to influence GH secretion from the pituitary in vitro (Hall et al. 1984) and exerts an inhibitory effect on GH secretion in adult rats only when injected i.c.v. (Netti et al. 1981 (Netti et al. , 1982 . Therefore, the increase in the releasable GH pool after removal of the inhibitory histaminergic tone is probably due to enhanced activity of hypothalamic GHRH neurons which in neonatal rats regulate not only the release but also the synthesis of GH (Cozzi et al. 1986 ). (Tuominen et al. 1996) .
Alternatively, a stimulatory action on GHRH mRNA induced by HA deprivation could be masked by the counteracting feedback effect on GHRH function of enhanced circulating levels of GH (Müller 1987 (Netti et al. 1984) .
Reduction of the histaminergic tone by -FMH in¬ creased the GH response to opioid stimulation in both neonatal and adult rats. The modulatory action of HA and opioids on GH secretion is reported to be exerted via an effect on the GHRH pathway (Netti et An alternative possibility, i.e. that a GH autofeed¬ back mechanism is responsible for the inhibition of GHRH mRNA levels (Müller 1987) , is discounted by the lack of enhanced basal GH levels and ensuing elevated hypothalamic SRIF mRNA levels.
In this context, it is also of interest to recall that short-term impairment of central HA activity affected somatotropic function differently in adult and neonatal rats. This is probably due to the immaturity of the central histaminergic system at birth, since HA levels in the hypothalamus reach adult values only 8-13 days after birth (Subramanian et 
